Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma, Small Cell × bemiparin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1 Carcinoma, Small Cell 1

Interventions

Pemetrexed 3 Gemcitabine 3 Topotecan 2 Carboplatin 2 vosaroxin 1 vinflunine 1 taxane 1 lurtotecan 1 liposomal doxorubicin 1 enzalutamide 1 bemiparin 1 apalutamide 1 abiraterone 1 Vinorelbine 1 RRx-001 1 Paclitaxel 1 Nivolumab 1 Irinotecan 1 Ipilimumab 1 Etoposide 1 Docetaxel 1 Cisplatin 1 Arsenic Trioxide 1 ARQ 197 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00324558 2012-06-08

Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY)

Clinica Universidad de Navarra, Universidad de Navarra

Phase 2 Terminated

Carcinoma, Small Cell, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡